Alterity Therapeutics (ATHE) Other Gross PP&E Adjustments (2015 - 2025)
Alterity Therapeutics' quarterly Other Gross PP&E Adjustments came in at -$60691.2 in Q4 2025, down 8.97% year-on-year from -$66673.3 in Q4 2024, and up 35.74% quarter-over-quarter from -$94449.8 in Q2 2025.
Alterity Therapeutics has reported Other Gross PP&E Adjustments for 11 years, with the latest figure at -$60691.2 in Q4 2025.
- For the quarter ending Q4 2025, Other Gross PP&E Adjustments fell 8.97% year-over-year to -$60691.2; the trailing twelve-month figure through Dec 2025 stood at -$60691.2 (down 8.97% YoY), and the FY2025 full-year result was -$94449.8, up 70.08% from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 stood at -$60691.2, up from -$94449.8 in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was $572.92 in Q4 2022, with the low at -$236124.8 in Q2 2024.
- Average Other Gross PP&E Adjustments over 5 years is -$78181.0, with a median of -$58192.7 recorded in 2024.
- Year-over-year, Other Gross PP&E Adjustments surged 105.71% in 2022 and plunged 11598.63% in 2023.
- Tracing ATHE's Other Gross PP&E Adjustments over 5 years: stood at -$10030.7 in 2021, then surged by 105.71% to $572.92 in 2022, then sank by 11598.63% to -$65878.3 in 2023, then increased by 15.46% to -$55694.2 in 2024, then fell by 8.97% to -$60691.2 in 2025.
- The last three Other Gross PP&E Adjustments figures came in at -$60691.2 (Q4 2025), -$94449.8 (Q2 2025), and -$55694.2 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -75.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -60,691.22 |
| Dec 31, 2025 | -60,691.22 |
| Jun 30, 2025 | -94,449.81 |
| Jun 30, 2025 | -94,449.81 |
| Dec 31, 2024 | -55,694.21 |
| Dec 31, 2024 | -55,694.21 |
| Jun 30, 2024 | -80,779.93 |
| Jun 30, 2024 | -80,779.93 |
| Dec 31, 2023 | -65,878.28 |
| Dec 31, 2023 | -65,878.28 |
| Jun 30, 2023 | -223,579.11 |
| Jun 30, 2023 | -223,579.11 |
| Dec 31, 2022 | 572.92 |
| Dec 31, 2022 | 572.92 |
| Jun 30, 2022 | -9,612.32 |
| Jun 30, 2022 | -9,612.32 |
| Dec 31, 2021 | -10,030.73 |
| Dec 31, 2021 | -10,030.73 |
| Jun 30, 2021 | -26,322.02 |
| Jun 30, 2021 | -26,322.02 |
| Dec 31, 2020 | 15,298.46 |
| Dec 31, 2020 | 15,298.46 |
| Jun 30, 2020 | 5,005.45 |
| Jun 30, 2020 | 5,005.45 |
| Dec 31, 2019 | 80,161.29 |
| Dec 31, 2019 | 80,161.29 |
| Jun 30, 2019 | 34,146.62 |
| Jun 30, 2019 | 34,146.62 |
| Dec 31, 2018 | 43,057.42 |
| Dec 31, 2018 | 43,057.42 |
| Jun 30, 2018 | 54,069.09 |
| Jun 30, 2018 | 54,069.09 |
| Dec 31, 2017 | 19,384.39 |
| Dec 31, 2017 | 19,384.39 |
| Jun 30, 2017 | 23,148.55 |
| Jun 30, 2017 | 23,148.55 |
| Jun 30, 2016 | 0.75 |
| Jun 30, 2016 | 0.75 |
| Dec 31, 2015 | -23,899.47 |
| Dec 31, 2015 | -23,899.47 |
| Jun 30, 2015 | -34,771.79 |
| Jun 30, 2015 | -34,771.79 |